Agena Bioscience®, a global provider of low-cost and high-throughput molecular testing solutions, today announced that its MassARRAY® SARS-CoV-2 Panel for
PNI will use the investment to advance a cost-effective Made-in-Canada COVID-19 vaccine PNI offers expertise in self-amplifying mRNA vectors, lipid-based
New capacity will serve unmet need in COVID-19 testing infrastructure CARLSBAD, CA – Argonaut Manufacturing Services, a contract manufacturing organization